Single-cell profiling of the antigen-specific response to BNT162b2 SARS-CoV-2 RNA vaccine | Nature Communications
Vector Design for Improved DNA Vaccine Efficacy, Safety and Production
Vaccines | Free Full-Text | Leishmaniac Quest for Developing a Novel Vaccine Platform. Is a Roadmap for Its Advances Provided by the Mad Dash to Produce Vaccines for COVID-19?
Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021 | MMWR
Vaccines | Free Full-Text | Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate
Pre-Clinical Development of BCG.HIVACAT, an Antibiotic-Free Selection Strain, for HIV-TB Pediatric Vaccine Vectored by Lysine Auxotroph of BCG | PLOS ONE
Recombinant Vaccine
Vaccine vial monitor (VVM)
Glycosite-deleted mRNA of SARS-CoV-2 spike protein as a broad-spectrum vaccine | PNAS
Development of a gene-deleted live attenuated candidate vaccine against fish virus (ISKNV) with low pathogenicity and high protection - ScienceDirect
Ensuring safety of DNA vaccines | Microbial Cell Factories | Full Text
Genetic components of a plasmid DNA vaccine. The essential components... | Download Scientific Diagram
Landscape and selection of vaccine epitopes in SARS-CoV-2 | Genome Medicine | Full Text
Insertion of a selectable marker by recombineering.(a) Targeting... | Download Scientific Diagram
Biomaterials at the interface of nano- and micro-scale vector–cellular interactions in genetic vaccine design - Journal of Materials Chemistry B (RSC Publishing) DOI:10.1039/C4TB01058B
Live attenuated vaccines, a favorable strategy to provide long-term immunity against protozoan diseases: Trends in Parasitology
A Selectable and Excisable Marker System for the Rapid Creation of Recombinant Poxviruses | PLOS ONE
The New Humanitarian | Coronavirus maps and humanitarian data: Tracking COVID-19 and vaccine rollouts
JCI - mRNA vaccine–induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer
Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes | Science
MYCOBACTERIUM COMPRISING EXPRESSION VECTOR WITH TWO AUXOTROPHIC SELECTION MARKERS AND ITS USE AS VACCINE - diagram, schematic, and image 13
Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens - ScienceDirect
